Michael Mannstadt retweeted
Happy International Women’s Day!
We’re celebrating women who have changed the world. Here are all of the amazing women who have received the #NobelPrize and their remarkable achievements at the time of the award.
Tell us about the women who inspire you the most - and why
#InternationalWomensDay
Michael Mannstadt retweeted
This year’s medicine laureates Victor Ambros and Gary Ruvkun studied a relatively unassuming 1 mm long roundworm, C. elegans.
Despite its small size, C. elegans possesses many specialised cell types such as nerve and muscle cells also found in larger, more complex animals, making it a useful model for investigating how tissues develop and mature in multicellular organisms.
Read how the 2024 medicine laureates’ investigations into C. elegans revealed an entirely new dimension to gene regulation: bit.ly/4dlPE6f
#NobelPrize
Michael Mannstadt retweeted
The ASBMR 2024 Annual Meeting Program Planner is now available! View the Highlights Abstracts Videos by experts in your scientific area, previewing scheduled abstract information content, and creating your schedule prior to arriving on site in Toronto. ativ.me/x5r
Michael Mannstadt retweeted
Our new study reveals widespread reproductive dysfunction in women during US Army Basic Combat Training—even among those who report regular menstrual cycles. bjsm.bmj.com/content/early/2… @MaryBouxsein @Julie_MHughes @thebbozz #WomensHealth
Michael Mannstadt retweeted
CUIMC’s Katrina Armstrong Has Agreed to Serve as Interim President of Columbia University president.columbia.edu/news/…
Michael Mannstadt retweeted
One of my favorite meetings each year. Phenomenal science and networking in beautiful Snowmass CO. Grateful for this nurturing community of bone and mineral researchers. I ❤️ my AIMM family! #AIMM2024
Michael Mannstadt retweeted
Phase 2 results from the #Calypso trial look very good! Thank you to everyone involved and to @AmolytPharma for this opportunity. Centres now open are Norwich & Leicester, Oxford next. academic.oup.com/jcem/advanc…
Michael Mannstadt retweeted
So thrilled for @EWYuMD and grateful for the donors who made this new award for early career clinical investigators possible! @mghfcendocrine @MGHBoneResearch @MGH_RI @CSR_MGH
Congratulations to the inaugural 2023 ASBMR Early Career Clinical Investigator Award Honoring Robert Marcus, M.D. Awardee Elaine Yu, M.D. (@EWYuMD)! Dr. Yu will receive her Esteemed Award at the 2023 ASBMR Annual Meeting in Vancouver, BC, Canada, October 13-16, 2023.
Michael Mannstadt retweeted
Exciting news to share!📢@JBMRPlus just received a first Journal Impact Factor of 3.8! Thank you to all Editors, Authors, Reviewers, and other contributors, and thank you to all of the @ASBMR members who have supported #JBMRPlus since its launch!🎉#openaccess #freetoread
Michael Mannstadt retweeted
To ASBMR Program Committee Clinical Co-Chair @SabsRamchand, #Pride means unconditional respect and acceptance. ASBMR embraces the diverse perspective of those that identify with the LGBTQIA+ community. Share what #Pride🌈means to you: asbmr.wufoo.com/forms/z1fhgy…
Michael Mannstadt retweeted
To ASBMR Social Media Committee Member @FayPapaioanMD, #Pride means to love others unconditionally. ASBMR embraces the diverse perspective of those that identify with the LGBTQIA+ community. Share what #Pride means to you: asbmr.wufoo.com/forms/z1fhgy…
Michael Mannstadt retweeted
Congratulations to the 2023 ASBMR Frost Award recipients! @ORSsociety
From top left to bottom right: Ahmed Al Saedi, @lenabatoon, Seoyeon Bok, Junyu Chen, Elise Jeffrey, @AmiLang_Science, @hayley_sabol, @LSurfactant, Josephine Tauer, & @MustafaUnal85
Michael Mannstadt retweeted
Research Summary: Acute Effects of Coffee Consumption on Health among Ambulatory Adults (CRAVE) nej.md/3FCvW8j
Michael Mannstadt retweeted
#BlackHistoryMonth Featured Member | @BoutinMd is a #FLARE2023 recipient (bit.ly/2N5iKxV). She shares her story explaining why professional development is important for her career. Watch her video (bit.ly/3kiKsL9). #DEI
Michael Mannstadt retweeted
Original Article: Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants nej.md/3Te6NGr
#nephrology #CKD
Michael Mannstadt retweeted
It's out! Congrats to @SeannaYoon for leading this study. So fun to work with this awesome team (@Meyer_M_B, @hankadel, @FisherLabMGH, @TheXavierLab, @GrekaLab, @RMorizane, @MMichael) and share new biology on vitamin D metabolism in @jclinicalinvest
jci.org/articles/view/163627
Michael Mannstadt retweeted
Congratulations to the 2023 John Haddad Young Investigator Award Recipients!
Diana Athonvarangkul, Stacy Ann Bailey, Po-Jung Chen, Madison Doolittle (@MadisonDoolitt3), Jessica Hathaway-Schrader, Elise Jeffery, Ben Kirk (@DrBenKirk), David Maridas, Jun Sun, & Samantha Weaver
Michael Mannstadt retweeted
Applications are now open for the 2023 John Haddad YI Awards! The ASBMR and AIMM are supporting the professional development of young investigators by offering awards to attend the meeting April 3-8, 2023, in Snowmass, Colorado. Apply by December 2!
ow.ly/NBEZ50Li0lu
Michael Mannstadt retweeted
As a mosquito magnet, I have a personal interest in this new report in @CellCellPress by Maria De Obaldia, @leslievosshall, & coworkers. They found that higher skin levels of long-chain carboxylic acids with ≥10 carbons distinguish 🦟 🧲 from non-magnets.
cell.com/cell/fulltext/S0092…

































